Ciclo celular / Checkpoint
Los inhibidores del ciclo celular/puntos de control son compuestos que interrumpen la progresión normal del ciclo celular, particularmente en puntos de control regulatorios clave. Estos inhibidores son cruciales para estudiar la división celular, comprender la proliferación de células cancerosas y desarrollar terapias anticancerígenas. Al dirigirse a fases específicas del ciclo celular, estos inhibidores pueden inducir la detención del ciclo celular, lo que lleva a apoptosis o senescencia en células de división rápida. En CymitQuimica, ofrecemos una amplia gama de inhibidores de alta calidad del ciclo celular/puntos de control para apoyar su investigación en biología del cáncer, biología celular y desarrollo de fármacos.
Subcategorías de "Ciclo celular / Checkpoint"
- Aurora quinasa(94 productos)
- CDK(500 productos)
- Detención del ciclo celular(4 productos)
- Chk(42 productos)
- DYRK(48 productos)
- Dynamin(23 productos)
- Ferroptosis(215 productos)
- HSP(169 productos)
- Integrin(224 productos)
- Kinesina(66 productos)
- LIM quinasa(19 productos)
- Asociado a microtúbulos(261 productos)
- PKC(102 productos)
- PLK(28 productos)
- ROCK(70 productos)
- Rho(2 productos)
- Wee1(15 productos)
- c-Myc(69 productos)
Mostrar 10 subcategorías más
Se han encontrado 3477 productos de "Ciclo celular / Checkpoint"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Nucleoside-Analog-1
CAS:<p>Nucleoside-Analog-1 is a 4′-Azidocytidine analogue, used to against Hepatitis C virus replication.</p>Fórmula:C9H9N5O5Pureza:98%Forma y color:SolidPeso molecular:267.2L-Fd4A
CAS:<p>L-Fd4A (compound 36) is an adenine derivative with anti-HIV (EC50=1.5μM) and anti-HBV (EC50=1.7μM) effects, low cytotoxicity.</p>Fórmula:C10H10FN5O2Forma y color:SolidPeso molecular:251.22BPKDi
CAS:<p>BPKDi is a potent and selective inhibitor of PKD (protein kinase D).</p>Fórmula:C21H28N6OPureza:98%Forma y color:SolidPeso molecular:380.49Aloisine A
CAS:<p>Aloisine A, a CDK/GSK-3 inhibitor with IC50: Cdk1/B-150nM, Cdk2/A-120nM, Cdk2/E-400nM, Cdk5/25-200nM, Cdk5/35-160nM, GSK-3α-500nM, GSK-3β-650nM, JNK-3-10μM.</p>Fórmula:C16H17N3OPureza:98%Forma y color:SolidPeso molecular:267.33CCT068127
CAS:<p>CCT068127 is a potent CDK2 and CDK9 inhibitor.</p>Fórmula:C19H27N7OForma y color:SolidPeso molecular:369.46hDHODH-IN-5
CAS:<p>hDHODH-IN-5 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH, IC50 = 0.91 μM).</p>Fórmula:C21H21F3N2O2Pureza:99.55%Forma y color:SolidPeso molecular:390.4DHODH-IN-13
CAS:<p>DHODH-IN-13 is an inhibitor of DHODH with IC50 of 4.3 μM for rat liver. DHODH-IN-13 can be used in studies about rheumatoid arthritis.</p>Fórmula:C10H6F3N3O3Pureza:99.66%Forma y color:SolidPeso molecular:273.17(S)-CR8
CAS:<p>(S)-CR8 is an effective second-generation cyclin-dependent kinase inhibitor.</p>Fórmula:C24H29N7OForma y color:SolidPeso molecular:431.53hDHODH-IN-3
CAS:<p>hDHODH-IN-3 is an inhibitor of human dihydroorotate dehydrogenase with a pMIC50 value of 8.6. hDHODH-IN-3 can inhibit measles virus replication.</p>Fórmula:C18H19BrN4O2Pureza:99.871%Forma y color:SolidPeso molecular:403.27BMVC
CAS:<p>BMVC is a potent G-quadruplex (G4) stabilizer and a selective telomerase inhibitor (IC50: ~0.2 μM) with anticancer activities.</p>Fórmula:C28H25I2N3Forma y color:SolidPeso molecular:657.33TP1287
CAS:<p>TP-1287 is an oral phosphate prodrug of the CDK9 inhibitor, alvocidib.</p>Fórmula:C21H21ClNO8PForma y color:SolidPeso molecular:481.82L-Cytidine
CAS:<p>L-Cytidine, pyrimidine nucleoside in RNA, regulates glial glutamate, brain lipids, catecholamines, and mitochondria.</p>Fórmula:C9H13N3O5Forma y color:SolidPeso molecular:243.22CDK2-IN-11
CAS:<p>CDK2-IN-11 inhibits CDK2 (IC50: 6.4 μM) and targets hCA II, IX, XII (Ki: 23.4-56.3 nM); suited for cancer research.</p>Fórmula:C18H14ClN7O2SForma y color:SolidPeso molecular:427.87Braco-19 trihydrochloride
CAS:<p>BRACO19 3HCl inhibits telomerase, blocking its capping function, and prevents HAdV viral replication.</p>Fórmula:C35H46Cl3N7O2Pureza:98.74%Forma y color:SolidPeso molecular:703.14(S)-LY3177833 hydrate
CAS:<p>(S)-LY3177833 ((S)-Example 2) hydrate, an orally active CDC7 kinase inhibitor, exhibits extensive in vitro anticancer efficacy.</p>Fórmula:C16H14FN5O2Forma y color:SolidPeso molecular:327.31Bofumustine
CAS:<p>Bofumustine is a chloroethyl nitrosourea with anti tumor properties.</p>Fórmula:C18H21ClN4O9Forma y color:SolidPeso molecular:472.83Levoleucovorin disodium
CAS:<p>Levoleucovorin disodium is the sodium salt of the enantiomerically active form of Folinic Acid.</p>Fórmula:C20H21N7Na2O7Pureza:98%Forma y color:SolidPeso molecular:517.41Nitracrine
CAS:<p>Nitracrine: a 1-nitroacridine, hypoxia-selective, anti-tumor agent; inhibits RNA synthesis, binds DNA reversibly and forms covalent adducts.</p>Fórmula:C18H20N4O2Pureza:98%Forma y color:SolidPeso molecular:324.38ProTAME
CAS:<p>ProTAME inhibits APC/CFzr & APC/CCdc20, enhances cell death with doxorubicin/etoposide in primary/MM cells, especially after TOPIIα upregulation.</p>Fórmula:C34H38N4O12SPureza:98%Forma y color:SolidPeso molecular:726.75Eg5 Inhibitor V, trans-24
CAS:<p>Eg5 Inhibitor V, trans-24 is a specific and potent Eg5 inhibitor that can be used in cancer research with an IC50 value of 0.65 uM.</p>Fórmula:C26H21N3O3Pureza:99.75%Forma y color:SolidPeso molecular:423.46DDD100097
CAS:<p>DDD100097 is a N-myristoyltransferase inhibitor with potential inhibitory effects on Trypanosoma brucei, which can be used to study neurological disorders.</p>Fórmula:C22H30Cl2F2N4O2SPureza:98.89%Forma y color:SolidPeso molecular:523.47LY 222306
CAS:<p>LY 222306 is a glycinamide ribonucleotide formyltransferase (GARFT) inhibitor with a Ki of 0.77 nM.</p>Fórmula:C19H23N5O7Pureza:98%Forma y color:SolidPeso molecular:433.42Ipivivint
CAS:<p>Ipivivint: orally active, potent CLK inhibitor; hinders CLK1, CLK2, & CLK3; curbs Wnt signaling & SRSF phosphorylation for cancer research.</p>Fórmula:C26H21FN8Forma y color:SolidPeso molecular:464.5DHODH-IN-8
CAS:<p>DHODH-IN-8 is a DHODH inhibitor with antimalarial properties, IC50: 0.13 μM (human), 47.4 μM (P. falciparum); Ki: 0.016 μM (human), 5.6 μM (P. falciparum).</p>Fórmula:C17H13ClN2O2Pureza:99.78%Forma y color:SolidPeso molecular:312.75AS-136A
CAS:<p>AS-136A is an orally active MV RdRp inhibitor with antiviral activity that inhibits measles virus and blocks viral RNA synthesis.</p>Fórmula:C17H19F3N4O3SPureza:98.52%Forma y color:SolidPeso molecular:416.42Synucleozid
CAS:<p>Synucleozid is a potent the SNCA mRNA inhibitor that encodes α-synuclein protein (IC50=1.5 μM), has the potential for the investigation of Parkinson’s disease.</p>Fórmula:C22H20N6Pureza:98%Forma y color:SolidPeso molecular:368.43OM-137
CAS:<p>OM137 inhibits Aurora kinases, impedes cell growth at high doses, and enhances low-dose paclitaxel effects.</p>Fórmula:C13H14N4O3SForma y color:SolidPeso molecular:306.34VRX-0466617
CAS:<p>VRX-0466617 is a novel selective Chk2 inhibitor.</p>Fórmula:C19H20BrN5O2SForma y color:SolidPeso molecular:462.36CDK2-IN-12
CAS:<p>CDK2-IN-12 (10b), potent CDK2 inhibitor, IC50: 11.6 μM; inhibits hCA I/II/IX/XII, KI: 3534/638.4/44.3/48.8 nM; anti-cancer properties.</p>Fórmula:C20H17N9O2SForma y color:SolidPeso molecular:447.47CDK8-IN-6
CAS:<p>CDK8-IN-6 (compound 9) is a potent inhibitor of cyclin-dependent kinase 8 (CDK8) (Kd: 13 nM), CDK8-IN-6 showed potential research value in AML cancers.</p>Fórmula:C26H37ClN2Forma y color:SolidPeso molecular:413.04KH-CB19
CAS:<p>KH-CB19 is an effective and highly specific inhibitor of the CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4).</p>Fórmula:C15H13Cl2N3O2Forma y color:SolidPeso molecular:338.19Dyrk1A-IN-3
CAS:<p>Dyrk1A-IN-3 is a selective DYRK1A inhibitor with an IC50 of 76 nM, useful for neurodegenerative disease research.</p>Fórmula:C18H16N6Forma y color:SolidPeso molecular:316.363,6-DMAD dihydrochloride
CAS:<p>3,6-DMAD dihydrochloride: Potent IRE1α-XBP1s inhibitor, affects IL-6 secretion and RNase activity, used in cancer research.</p>Fórmula:C22H33Cl2N5Forma y color:SolidPeso molecular:438.44CDK5 inhibitor 20-223
CAS:<p>CDK5 inhibitor 20-223 is a potent CDK2/CDK5 inhibitor,anti-Colorectal Cancer (CRC), inhibiting cell migration and inducing cell cycle arrest.</p>Fórmula:C19H19N3OForma y color:SolidPeso molecular:305.37PF-4950834
CAS:<p>PF-4950834, a ATP-competitive, selective Rho kinase inhibitor, provides therapeutic benefits in chronic inflammatory diseases.</p>Fórmula:C21H19N3O2Pureza:98%Forma y color:SolidPeso molecular:345.39PV-1115
CAS:<p>PV-1115 is an effective and highly selective inhibitor of the Chk2.</p>Fórmula:C20H19N7O3Pureza:98%Forma y color:SolidPeso molecular:405.412-Fluoroadenine
CAS:<p>2-Fluoroadenine (NSC-27364) has toxicity in nonproliferating and proliferating tumor cells. 2-Fluoroadenine can be used for anticancer studies.</p>Fórmula:C5H4FN5Pureza:98.84% - 99.62%Forma y color:White To Light Yellow Crystal PowderPeso molecular:153.12HIV-1 inhibitor-43
CAS:<p>HIV-1 Inhibitor-43 suppresses HIV-1, with EC50: 21.3 nM (Y188L), 6.2 nM (K103N-Y181C), <0.7 nM (K103N/Y181C), and lowers HIV RNA/p24 protein.</p>Fórmula:C24H21ClN2O4SForma y color:SolidPeso molecular:468.95Litronesib Racemate
CAS:<p>Litronesib is a selective, allosteric inhibitor of kinesin Eg5.Litronesib (Racemate) is the racemate of litronesib.</p>Fórmula:C23H37N5O4S2Forma y color:SolidPeso molecular:511.7GP29
CAS:<p>GP29 is a Type II kinase inhibitor of the IRE1α endoribonuclease that acts by targeting the ATP-binding pocket of IRE1α.</p>Fórmula:C33H28F3N5O3Pureza:98%Forma y color:SolidPeso molecular:599.6BMVC2
CAS:<p>BMVC2 (o-BMVC), a carbazole derivative of BMVC, is a G-quadruplex (G4) stabilizer.</p>Fórmula:C28H25I2N3Forma y color:SolidPeso molecular:657.33BMH-22
CAS:<p>BMH-22 is an RNA polymerase I inhibitor that acts by causing nucleolar stress and showing potent anticancer activity across many tumor types.</p>Fórmula:C16H17N3Forma y color:SolidPeso molecular:251.33MSC-1186
CAS:<p>MSC-1186 selectively inhibits SRPKs—IC50: 2.7nM (SRPK1), 81nM (SRPK2), 0.6nM (SRPK3)—for cancer research.</p>Fórmula:C19H17ClFN7O2SForma y color:SolidPeso molecular:461.9(Rac)-Managlinat dialanetil
CAS:<p>Managlinat dialanetil, an orally available and potent inhibitor of fructose 1,6-bisphosphatase (FBPase) used in research 2 type diabetes.</p>Fórmula:C21H33N4O6PSPureza:98.52%Forma y color:SolidPeso molecular:500.55Carbonic anhydrase inhibitor 14
CAS:<p>CA inhibitor 14 blocks hCA I/II/IX/XII (K i of 1203/99.7/9.4/27.7 nM) and CDK2 (IC50: 20.3 μM), showing antitumor effects.</p>Fórmula:C18H17N7O2SForma y color:SolidPeso molecular:395.44DHODH-IN-12
CAS:<p>DHODH-IN-12 is a leflunomide derivative and a weak dihydrorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.07.</p>Fórmula:C10H9N3O2Pureza:99.53%Forma y color:SolidPeso molecular:203.2Bis-Pro-5FU
CAS:<p>Bis-Pro-5FU enhances oral uptake and safety of 5-FU, an anti-cancer drug for colorectal and pancreatic tumors.</p>Fórmula:C10H7FN2O2Forma y color:SolidPeso molecular:206.17DHODH-IN-20
CAS:<p>Dhodh-in-20 (Compound 133), a potent DHODH inhibitor, may help study acute myeloid leukemia and inhibit tumor growth.</p>Fórmula:C24H25F4N3O3Forma y color:SolidPeso molecular:479.47CGP 53353
CAS:<p>CGP 53353 (DAPH-7) is a PKC inhibitor with inhibitory effects on PKCβII and PKCβI and can be used to study atherosclerosis.</p>Fórmula:C20H13F2N3O2Pureza:98.11%Forma y color:SolidPeso molecular:365.33Fozivudine tidoxil
CAS:<p>Fozivudine tidoxil, a reverse transcriptase inhibitor, is used potentially for the treatment of HIV infection.</p>Fórmula:C35H64N5O8PSForma y color:SolidPeso molecular:745.95JFN05510
CAS:<p>Compound: 3'-O-tert-BDMS-5'-O-DMT-N2-IBG 2'-CE phosphoramidite; has anticancer properties and activates enzymes.</p>Fórmula:C50H68N7O9PSiForma y color:SolidPeso molecular:970.18Aditoprime
CAS:<p>Aditoprime inhibits bacterial growth by blocking DHFR, effective against L.casei and E.coli with IC50 of 520/47 nM.</p>Fórmula:C15H21N5O2Forma y color:SolidPeso molecular:303.36PKC-9
CAS:<p>PKC-9 is a PKC-zeta inhibitor 9.</p>Fórmula:C25H25N7Forma y color:SolidPeso molecular:423.512-Keto-D-galactose
CAS:<p>2-Keto-D-galactose inhibits DNA synthesis and inhibits the proliferation of in vitro grown Ehrlich ascites tumor cells.</p>Fórmula:C6H10O6Pureza:98%Forma y color:SolidPeso molecular:178.14CAP-53194
CAS:<p>CAP-53194 is a selective Plk1 inhibitor.</p>Fórmula:C21H14N6O5Pureza:98%Forma y color:SolidPeso molecular:430.37GSK-3008348
CAS:<p>GSK-3008348 is an antagonist of integrin alpha(v)beta6.</p>Fórmula:C29H37N5O2Pureza:99.547%Forma y color:SolidPeso molecular:487.64Mivobulin Isethionate
CAS:<p>Mivobulin, a tubulin inhibitor (CI-980), may treat glioma, melanoma, prostate, and ovarian cancer, targeting colchicine-binding site.</p>Fórmula:C19H25N5O6SPureza:98%Forma y color:SolidPeso molecular:451.5BAY-707
CAS:<p>BAY-707: tolerable in mice, no anticancer efficacy; potent, selective MTH1 inhibitor, IC50 = 2.3 nM; good PK profile.</p>Fórmula:C15H20N4O2Pureza:98%Forma y color:SolidPeso molecular:288.34Picoplatin
CAS:<p>Picoplatin, an anti-cancer agent overcoming platinum resistance, alkylates DNA to block replication, transcription, and induce apoptosis.</p>Fórmula:C6H10Cl2N2PtPureza:98%Forma y color:SolidPeso molecular:376.14HHL-6
CAS:<p>HHL-6 is a c-Fos and BDNF protein expression modulator.</p>Fórmula:C19H26N2O3Forma y color:SolidPeso molecular:330.42Fosteabine
CAS:<p>Fosteabine is an oral and prodrug analog of cytarabine. It is resistant to deoxycytidine deaminase.</p>Fórmula:C27H50N3O8PPureza:98%Forma y color:SolidPeso molecular:575.67Metralindole HCl
CAS:<p>Metralindole is a reversible monoamine oxidase A (RIMA) inhibitor, it was investigated as a potential antidepressant.</p>Fórmula:C15H18ClN3OPureza:98%Forma y color:SolidPeso molecular:291.78HR22C16
CAS:<p>HR22C16 is an effective, selective, and cell-permeable mitotic kinesin Eg5 inhibitor.</p>Fórmula:C23H23N3O3Forma y color:SolidPeso molecular:389.45HIPP
CAS:<p>HIPP is a highly selective inhibitor of antineoplastic CtBP.</p>Fórmula:C9H9NO3Forma y color:SolidPeso molecular:179.17NPD9948
CAS:<p>NPD9948 is a competitive inhibitor of MTH1.</p>Fórmula:C13H14N6Forma y color:SolidPeso molecular:254.29LDN-209929
CAS:<p>LDN-209929 2HCl is a potent and selective inhibitor of haspin kinase.</p>Fórmula:C17H17ClN2OSForma y color:SolidPeso molecular:332.85DYRKi
CAS:<p>DYRKi is a nontoxic, DYRK1-selective inhibitor.</p>Fórmula:C20H13F3N4O2SForma y color:SolidPeso molecular:430.4BIPM
CAS:<p>BIPM inhibits ROCK2, alters SH-SY5Y cell migration, actin fibers, neurite length, and reduces cofilin phosphorylation.</p>Fórmula:C23H22N2O3Forma y color:SolidPeso molecular:374.43Cdc7-IN-14
CAS:<p>Cdc7-IN-14 (compound 82) is a potent CDC7 inhibitor with an IC50 < 1 nM, promising for cancer research.</p>Fórmula:C18H20N4O2SForma y color:SolidPeso molecular:356.44Rho-Kinase-IN-2
CAS:<p>Rho-Kinase-IN-2, an oral ROCK inhibitor (IC50=3nM), penetrates the CNS; potential in Huntington's research.</p>Fórmula:C20H25FN4O2Forma y color:SolidPeso molecular:372.44L-Guanosine
CAS:<p>L-Guanosine is the L-configuration of Guanosine. Guanosine is a purine nucleoside that has anti-herpesvirus activity [1] [2].</p>Fórmula:C10H13N5O5Forma y color:SolidPeso molecular:283.24REV7/REV3L-IN-1
CAS:<p>REV7/REV3L-IN-1 is a inhibitor of REV7/REV3L interaction(IC50 of 78 μM),</p>Fórmula:C19H21N3O3SPureza:98%Forma y color:SolidPeso molecular:371.45NSC47924
CAS:<p>NSC47924 is a laminin receptor (LR) inhibitor.</p>Fórmula:C18H17NO2Pureza:98%Forma y color:SolidPeso molecular:279.33AB-182
CAS:<p>AB-182 is an aziridine derivative with antitumor activity.</p>Fórmula:C11H22N3O4PForma y color:SolidPeso molecular:291.28Ro 43-5054
CAS:<p>Ro 43-5054 is a small molecular, noncyclic peptidomimetic inhibitor.</p>Fórmula:C24H27N5O7Pureza:98%Forma y color:SolidPeso molecular:497.5ROCK-IN-D1
CAS:<p>ROCK-IN-D1 is an effective and selective inhibitor of ROCK.</p>Fórmula:C22H27N5O2SPureza:98%Forma y color:SolidPeso molecular:425.55UIAA-II-232
CAS:<p>UIAA-II-232 (compound 19b) is a potent inhibitor of DNA gyrase catalytic (IC 50= 3.5 μM).</p>Fórmula:C20H24FN5O3Forma y color:SolidPeso molecular:401.43Protein kinase D inhibitor 1
CAS:<p>Protein kinase D inhibitor 1 (17m) is a potent pan-PKD suppressant with IC50 of 17-35 nM, targeting cortactin phosphorylation.</p>Fórmula:C19H21N7Forma y color:SolidPeso molecular:347.42SNX2-1-108
CAS:<p>SNX2-1-108 is a selective CDK8 and CDK19 inhibitor.</p>Fórmula:C21H16N4Pureza:98%Forma y color:SolidPeso molecular:324.38LIMK-IN-14
CAS:<p>LIMK-IN-14 is an effective and selective inhibitor of LIMK.</p>Fórmula:C22H27N7O3Pureza:98%Forma y color:SolidPeso molecular:437.49Denopterin
CAS:<p>Denopterin is an antineoplastic agent.</p>Fórmula:C21H23N7O6Pureza:98%Forma y color:SolidPeso molecular:469.45RK-9123016
CAS:<p>RK-9123016 is a SIRT2 inhibitor.</p>Fórmula:C16H18N6O3SPureza:99.65%Forma y color:SolidPeso molecular:374.421-Acetyl-3-o-toluyl-5-fluorouracil
CAS:<p>1-Acetyl-3-o-toluyl-5-fluorouracil is a potent antineoplastic agent.</p>Fórmula:C14H11FN2O4Pureza:98%Forma y color:SolidPeso molecular:290.25MK-0668
CAS:<p>MK-0668 is a very potent and orally active very late antigen-4 antagonist.</p>Fórmula:C31H30Cl2N6O6SForma y color:SolidPeso molecular:685.58BI-831266
CAS:<p>BI-831266 is a potent and selective Aurora kinase B inhibitor.</p>Fórmula:C27H38ClN7O2Forma y color:SolidPeso molecular:528.09Aurora Kinases-IN-2
CAS:<p>Aurora Kinases-IN-2 (12Aj) hinders Aurora A/B kinases (IC50: 90/152 nM), used in cancer studies.</p>Fórmula:C22H18ClN5O3Forma y color:SolidPeso molecular:435.86Rabacfosadine succinate
CAS:<p>Rabacfosadine succinate is the acyclic nucleoside phosphonate PMEG double prodrug.</p>Fórmula:C25H41N8O10PPureza:98%Forma y color:SolidPeso molecular:644.623Thiamiprine
CAS:<p>Thiamiprine is an agent with the activity of antineoplastic.</p>Fórmula:C9H8N8O2SForma y color:SolidPeso molecular:292.28Meturedepa
CAS:<p>Meturedepa is an antineoplastic agent.</p>Fórmula:C11H22N3O3PPureza:98%Forma y color:SolidPeso molecular:275.28BMH-23
CAS:<p>BMH-23 is an RNA polymerase I inhibitor that acts by causing nucleolar stress and showing potent anticancer activity across many tumor types.</p>Fórmula:C15H15N3Pureza:98%Forma y color:SolidPeso molecular:237.3(R)-DRF053 dihydrochloride
CAS:<p>cdk/CK1 inhibitor,potent and ATP-competitive</p>Fórmula:C23H29Cl2N7OPureza:98%Forma y color:SolidPeso molecular:490.43BzDANP
CAS:<p>BzDANP is a modulator of pre-miR-29a maturation by Dicer.</p>Fórmula:C18H24N6Forma y color:SolidPeso molecular:324.42L 703014
CAS:<p>L 703014 is an antagonist of the fibrinogen receptor.</p>Fórmula:C24H34N4O4Pureza:98%Forma y color:SolidPeso molecular:442.55SEC inhibitor KL-2
CAS:<p>KL-2: potent SEC inhibitor, selectively disrupts AFF4-CCNT1, dose-dependent, Ki: 1.50 μM.</p>Fórmula:C17H13ClFNO3Pureza:99.86%Forma y color:SolidPeso molecular:333.74Aurora kinase inhibitor-9
CAS:<p>Aurora kinase inhibitor-9 (9d) targets AURKA/B with IC50: 0.093 μM for A and 0.09 μM for B, with wide anti-proliferative effects.</p>Fórmula:C19H17Cl2N3O4SForma y color:SolidPeso molecular:454.33PV-1019
CAS:<p>PV-1019 (NSC 744039), a potent Chk2 inhibitor, has an IC50 of 24 nM and blocks Chk2 autophosphorylation and IR-induced apoptosis.</p>Fórmula:C18H17N7O3Forma y color:SolidPeso molecular:379.37LSN 3213128
CAS:<p>LSN 3213128: a potent oral antifolate targeting AICARFT with IC50s of 16 nM (enzyme) and 19 nM (cells), offers anti-tumor effects.</p>Fórmula:C17H16FN3O4S2Forma y color:SolidPeso molecular:409.45JTK-101
CAS:<p>JTK-101 is a potent and selective Tat-dependent HIV-1 replication inhibitor.</p>Fórmula:C25H23N3O3Forma y color:SolidPeso molecular:413.47Scaff10-8
CAS:<p>Scaff10-8 blocks AKAP-Lbc-RhoA, aiding aquaporin-2 movement in kidney cells.</p>Fórmula:C22H18O6Pureza:98%Forma y color:SolidPeso molecular:378.37LDN-209929 dihydrochloride
CAS:<p>LDN-209929 dihydrochloride: potent haspin kinase inhibitor, 55 nM IC50, 180x more selective than DYRK2.</p>Fórmula:C17H19Cl3N2OSForma y color:SolidPeso molecular:405.77
